Anxiety Disorder Research
Online ISSN : 2187-9583
Print ISSN : 1883-5619
ISSN-L : 1883-5619
Current issue
Displaying 1-7 of 7 articles from this issue
Foreword
Reviews
  • Takeshi Otowa
    2014Volume 5Issue 2 Pages 73-84
    Published: March 31, 2014
    Released on J-STAGE: May 02, 2014
    JOURNAL FREE ACCESS
    This review provides a broad overview of the state of research in the genetics of the major anxiety disorders (ADs). Overall, genetic epidemiological studies support a moderate level of familial aggregation (odds ratio: 4–6) and heritability estimates are about 30–50%. Twin studies suggest that the genetic architecture of ADs is not isomorphic with their classifications, sharing risk factors with each other and related phenotypes such as depression and anxious personality traits. Linkage and association studies of ADs have produced inconclusive results. Recently, genome-wide association studies with larger samples have been conducted to identify susceptibility genes for ADs. Animal studies provide a promising complimentary approach to human studies, since animal models for anxiety phenotypes are among the best validated across psychiatry. Gene environmental interaction and epigenetic studies may be important fields in the future research of genetics of ADs.
    Download PDF (488K)
  • Masayuki Sekiguchi
    2014Volume 5Issue 2 Pages 85-92
    Published: March 31, 2014
    Released on J-STAGE: May 02, 2014
    JOURNAL FREE ACCESS
    Conditioned fear memory is critical for behavioral adaptation to the environment surrounding an individual. It is widely accepted that this implicit memory and its abnormal control are involved in the pathogenesis of anxiety disorders in which fear is a contributory factor. Identification of the biological system that plays a modulatory role in conditioned fear memory is fundamental to understanding the adjustment of these memory processes. In this brief review, we introduced recent findings of ours and other researchers on the control of conditioned fear memory. It is expected that elucidation of the control mechanisms aids in developing new treatment for anxiety disorders.
    Download PDF (462K)
  • Daisuke Fujisawa
    2014Volume 5Issue 2 Pages 93-101
    Published: March 31, 2014
    Released on J-STAGE: May 02, 2014
    JOURNAL FREE ACCESS
    Anxiety symptoms are frequently seen in palliative care settings. Clinicians have to judge whether and how they intervene with patients' and family's anxiety, depending on severity and time course of the symptoms. Severity of anxiety should be evaluated according to the level of patients' distress and the level of their functional impairment. There are sufficient amount of evidence that support effectiveness of psychotherapy. Also, use of pharmacotherapies are widely practiced, despite there is still room for further studies. It is an art of clinician's skills how to tailor treatment strategies that are allied with patients' goals and expectations.
    Download PDF (573K)
Research Notes
feedback
Top